Natco Pharma launches branded drug for lung cancer | Medicexchange News
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange

Natco Pharma launches branded drug for lung cancer

Medicexchange News - Medicexchange News
MUMBAI (Reuters) - Natco Pharma Ltd. on Tuesday announced the launch of Pemetrexed, used in the treatment of advanced cell lung cancer.

The injectible drug was being launched under the brand name of Pemnat and would be sold in 20 ml vials.

Shares in Natco Pharma were up 3.4 percent at 120.10 rupees in a weak Mumbai market.